Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
Clinical trial NCT02360319 · COMPLETED
Trial details
- NCT number
- NCT02360319
- Sponsor
- Vanguard Research Group
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-11
- Primary completion
- 2019-03-31
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.